Compounds > 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
Page last updated: 2024-09-02

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Malignant Melanoma

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Malignant Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balch, C; Bartolucci, AA; Presant, CA; Troner, M1
Benjamin, RS; Bodey, GP; Burgess, MA; Gottlieb, JA; Keating, MJ; Livingston, RA; McCredie, KB; Rodriguez, V; Valdivieso, M1
Bartolucci, AA; Oldham, R; Presant, CA; Ungaro, P1

Trials

2 trial(s) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Malignant Melanoma

ArticleYear
A randomized comparison of cyclophosphamide, DTIC with or without piperazinedione in metastatic malignant melanoma.
    Cancer, 1982, Apr-01, Volume: 49, Issue:7

    Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Piperazines; Random Allocation; Skin Neoplasms

1982
Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia.
    Cancer treatment reports, 1979, Volume: 63, Issue:6

    Topics: Adult; Antibiotics, Antineoplastic; Bone Marrow; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Melanoma; Neoplasms; Piperazines

1979

Other Studies

1 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Malignant Melanoma

ArticleYear
Phase II trial of piperazinedione in malignant melanoma: a report by the Southeastern Cancer Study Group.
    Cancer treatment reports, 1979, Volume: 63, Issue:8

    Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Drug Evaluation; Humans; Lung Neoplasms; Melanoma; Piperazines; Skin Neoplasms; Thrombocytopenia

1979